AdaptHealth (AHCO) Gains from Investment Securities (2020 - 2024)

AdaptHealth's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at -$2.2 million for Q4 2024.

• On a quarterly basis, Gains from Investment Securities rose 14.45% year-over-year to -$2.2 million in Q4 2024; TTM through Sep 2025 was -$2.2 million, a 48.81% increase from a year earlier, with the FY2024 full-year figure at -$4.0 million, up 88.34% from the prior year.
• Gains from Investment Securities improved to -$2.2 million in Q4 2024 per AHCO's latest filing, from -$2.2 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $63.0 million in Q4 2020 and bottomed at -$37.5 million in Q2 2021.
• The 5-year median for Gains from Investment Securities is -$1.5 million (2023), against an average of $1.3 million.
• Across the five-year window, Gains from Investment Securities tumbled 19869.23% in 2023 and jumped 134.22% in 2024, its largest moves.
• Year by year, Gains from Investment Securities stood at $63.0 million in 2020, then tumbled by 93.36% to $4.2 million in 2021, then slumped by 100.31% to -$13000.0 in 2022, then tumbled by 19869.23% to -$2.6 million in 2023, then grew by 14.45% to -$2.2 million in 2024.
• Per Business Quant, the three latest AHCO Gains from Investment Securities figures stand at -$2.2 million (Q4 2024), -$2.2 million (Q3 2024), and -$7.0 million (Q2 2024).